News Chart Arrowhead Pharmaceuticals, Inc.

Equities

ARWR

US04280A1007

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 20/05/2026 BST			5-day change	1st Jan Change
77.14 ^USD	+5.41%		-0.95%	+16.19%

05-15	Arrowhead Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 through May-14-2026
05-08	RBC Capital Adjusts Arrowhead Pharmaceuticals Price Target to $87 From $80, Maintains Outperform Speculative Risk Rating	MT

7cb810beb456a676e7fa171bf766809.PkSrRGixQEGUVAh0Jfaoi1cVvCuYOEK7yTo1_2_BTsU.eAnZMg-BcibGAWIQHdvf0ydU20H9Xh2Jg01kyVyAI71UAJgcBdQzFaBiPA~c682567b0c0bfc27cf5c0868657f713b